{"success":true,"data":{"pressRelease":{"id":"169636","rtpr_id":"nNFC8qrS5N-20261014","ticker":"MOOD","exchange":"","all_tickers":["MOOD"],"title":"Doseology Announces Resignation of Director","author":"Newsfile Corp","published_at":"2026-10-14T22:00:18.010Z","article_body":"Kelowna, British Columbia--(Newsfile Corp. - October 14, 2026) - Doseology\nSciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) (\"Doseology\" or the\n\"Company\") a consumer product innovation company focused on oral pouch and\nfunctional stimulant product technologies, announces that Larry Latowsky has\nresigned as a director of the Company, effective immediately.\n\nAbout Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70)\n\nDoseology Sciences Inc. specializes in pouch-based oral stimulant and\ncognitive support products. The rapidly expanding oral stimulant pouch sector\nis gaining momentum as consumers seek modern, discreet alternatives to\ntraditional delivery formats. Unlike combustible tobacco or vape products,\noral stimulant pouches are smokeless and vapor-free, providing an alternative\ndelivery method without inhalation.\n\nFrom a market perspective, the oral pouch category is experiencing strong\nglobal growth as consumers increasingly prioritize convenience, portability,\nand format innovation. The pouch sector represents one of the most dynamic and\nhigh-growth areas in modern functional consumer products.\n\nFor more information visit:\n\nCorporate: www.doseology.com\n\nOn behalf of the Board of Directors,\nKareem Baalbaki\nInterim CEO\nDoseology Sciences Inc.\n\nInvestor & Media Contact:\nEmail: hello@doseology.com\nPhone: 825.800.0115\n\nNo securities regulatory authority has either approved or disapproved of the\ncontents of this press release.\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/319077","article_body_html":"","raw_payload":{"data":{"id":"nNFC8qrS5N-20261014","title":"Doseology Announces Resignation of Director","author":"Newsfile Corp","ticker":"MOOD","created":"2026-10-14T22:00:18.010Z","tickers":["MOOD"],"exchange":"","article_body":"Kelowna, British Columbia--(Newsfile Corp. - October 14, 2026) - Doseology\nSciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70) (\"Doseology\" or the\n\"Company\") a consumer product innovation company focused on oral pouch and\nfunctional stimulant product technologies, announces that Larry Latowsky has\nresigned as a director of the Company, effective immediately.\n\nAbout Doseology Sciences Inc. (CSE: MOOD) (OTCQB: DOSEF) (FSE: VU70)\n\nDoseology Sciences Inc. specializes in pouch-based oral stimulant and\ncognitive support products. The rapidly expanding oral stimulant pouch sector\nis gaining momentum as consumers seek modern, discreet alternatives to\ntraditional delivery formats. Unlike combustible tobacco or vape products,\noral stimulant pouches are smokeless and vapor-free, providing an alternative\ndelivery method without inhalation.\n\nFrom a market perspective, the oral pouch category is experiencing strong\nglobal growth as consumers increasingly prioritize convenience, portability,\nand format innovation. The pouch sector represents one of the most dynamic and\nhigh-growth areas in modern functional consumer products.\n\nFor more information visit:\n\nCorporate: www.doseology.com\n\nOn behalf of the Board of Directors,\nKareem Baalbaki\nInterim CEO\nDoseology Sciences Inc.\n\nInvestor & Media Contact:\nEmail: hello@doseology.com\nPhone: 825.800.0115\n\nNo securities regulatory authority has either approved or disapproved of the\ncontents of this press release.\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/319077"},"type":"article","timestamp":"2026-10-14T22:00:18.052419574Z","server_sent_at_ms":1792015218052},"received_at":"2026-10-14T22:00:18.104Z","source_url":"https://www.newsfilecorp.com/release/319077"},"analysis":{"id":"157867","press_release_id":"169636","analysis_json":{"industry":{"label":"Tobacco","sector":"Consumer Staples"},"redFlags":["director resignation effective immediately with no stated reason or successor","company led by Interim CEO, compounding leadership instability"],"eventType":"board_change","narrative":"Doseology Sciences announced that director Larry Latowsky has resigned from the board, effective immediately.\n\nNo reason for the departure or successor was provided; Kareem Baalbaki remains Interim CEO on behalf of the board.\n\nFor a micro-cap with an interim CEO already in place, another unexplained board exit adds governance uncertainty, though the operational impact appears limited.","sentiment":"bearish","agentHooks":{"shouldPost":false,"suggestedAngle":"Unexplained director exit at micro-cap with interim CEO — watch for further governance churn."},"keyFigures":{},"namedEntities":{"people":[{"name":"Larry Latowsky","role":"resigning director"},{"name":"Kareem Baalbaki","role":"Interim CEO"}],"products":[],"companies":[{"name":"Doseology Sciences Inc.","ticker":"MOOD"}],"dollarAmounts":[]},"materialImpact":{"score":2,"reasoning":"Routine director resignation with no stated successor, cause, or board strategy change. Slightly negative given no explanation and interim CEO already in place at a micro-cap."},"tickerRelevance":{"others":[{"ticker":"DOSEF","relevance":"mentioned"},{"ticker":"VU70","relevance":"mentioned"}],"primary":"MOOD"},"globalImportance":12,"audienceRelevance":8,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap","eventGravity":"routine-board-change","issuerAuthored":true,"leadershipInstability":true}},"event_type":"board_change","event_type_secondary":null,"sentiment":"bearish","material_impact_score":2,"narrative":"Doseology Sciences announced that director Larry Latowsky has resigned from the board, effective immediately.\n\nNo reason for the departure or successor was provided; Kareem Baalbaki remains Interim CEO on behalf of the board.\n\nFor a micro-cap with an interim CEO already in place, another unexplained board exit adds governance uncertainty, though the operational impact appears limited.","key_figures":{},"named_entities":{"people":[{"name":"Larry Latowsky","role":"resigning director"},{"name":"Kareem Baalbaki","role":"Interim CEO"}],"products":[],"companies":[{"name":"Doseology Sciences Inc.","ticker":"MOOD"}],"dollarAmounts":[]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-14T22:00:21.436Z","global_importance":12,"audience_relevance":8,"importance_components":{"tickerTier":"micro-cap","eventGravity":"routine-board-change","issuerAuthored":true,"leadershipInstability":true}},"durationMs":3319,"modelName":"glm-5.3-flashx"}}